4.6 Article

Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma

Journal

PLOS GENETICS
Volume 13, Issue 8, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pgen.1006879

Keywords

-

Funding

  1. Wellcome Trust
  2. National Institute for Health Research
  3. Cancer Research UK
  4. Cancer Research UK [15874, 19556] Funding Source: researchfish
  5. Cancer Research UK
  6. Versus Arthritis [20406] Funding Source: researchfish

Ask authors/readers for more resources

Oesophageal adenocarcinoma (OAC) is one of the ten most prevalent forms of cancer and is showing a rapid increase in incidence and yet exhibits poor survival rates. Compared to many other common cancers, the molecular changes that occur in this disease are relatively poorly understood. However, genes encoding chromatin remodeling enzymes are frequently mutated in OAC. This is consistent with the emerging concept that cancer cells exhibit reprogramming of their chromatin environment which leads to subsequent changes in their transcriptional profile. Here, we have used ATAC-seq to interrogate the chromatin changes that occur in OAC using both cell lines and patient-derived material. We demonstrate that there are substantial changes in the regulatory chromatin environment in the cancer cells and using this data we have uncovered an important role for ETS and AP1 transcription factors in driving the changes in gene expression found in OAC cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Medicine, Research & Experimental

Hereditary Diffuse Gastric Cancer: Approaches to Screening, Surveillance, and Treatment

Nastazja Dagny Pilonis, Marc Tischkowitz, Rebecca C. Fitzgerald, Massimiliano di Pietro

Summary: Hereditary diffuse gastric cancer (HDGC) is a rare cancer syndrome associated with significant risks of gastric and lobular breast cancer, often presenting late in clinical settings. While most cases can be traced back to germline variants in the CDH1 gene, some families with clustering of DGC do not have a clear genetic cause. This review focuses on discussing key elements for assessing inherited DGC susceptibility, providing practical recommendations for surveillance and treatment of at-risk individuals and early-stage patients.

ANNUAL REVIEW OF MEDICINE, VOL 72, 2021 (2021)

Article Gastroenterology & Hepatology

Utility and Cost-Effectiveness of a Nonendoscopic Approach to Barrett's Esophagus Surveillance After Endoscopic Therapy

Swathi Eluri, Anna Paterson, Brianna N. Lauren, Maria O'Donovan, Pradeep Bhandari, Massimiliano di Pietro, Minyi Lee, Rehan Haidry, Laurence Lovat, Krish Ragunath, Chin Hur, Rebecca C. Fitzgerald, Nicholas J. Shaheen

Summary: This study assessed the application value of Cytosponge in BE patients after RFA. The results showed that Cytosponge testing is a cost-effective surveillance method and is strongly associated with residual BE after ablation.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Developing patient-orientated Barrett's oesophagus services: the role of dedicated services

Elizabeth Ratcliffe, James Britton, Shaheen Hamdy, John McLaughlin, Yeng Ang

Summary: This review explores the emerging role of dedicated services for patients with Barrett's oesophagus (BO). The research indicates that dedicated services can improve guideline adherence and increase dysplasia detection rates. Additionally, patients report high levels of cancer worry and poor disease-specific knowledge.

BMJ OPEN GASTROENTEROLOGY (2022)

Review Biochemistry & Molecular Biology

The future of early cancer detection

Rebecca C. Fitzgerald, Antonis C. Antoniou, Ljiljana Fruk, Nitzan Rosenfeld

Summary: Proactively detecting cancer at an early stage is crucial, but distinguishing inconsequential changes from life-threatening lesions can be challenging. Advancements in technology will aid real-time detection of personalized cancer signals. Risk-based detection and prevention should be cost effective and widely accessible.

NATURE MEDICINE (2022)

Review Multidisciplinary Sciences

Early detection of cancer

David Crosby, Sangeeta Bhatia, Kevin M. Brindle, Lisa M. Coussens, Caroline Dive, Mark Emberton, Sadik Esener, Rebecca C. Fitzgerald, Sanjiv S. Gambhir, Peter Kuhn, Timothy R. Rebbeck, Shankar Balasubramanian

Summary: Early detection of cancer is crucial for improving survival rates, but unfortunately, a significant number of cases are diagnosed at an advanced stage. Overcoming various challenges is essential to achieve early detection for all cancers, including understanding high-risk individuals, elucidating the biology and trajectory of precancer and early cancer, and developing sensitive and specific detection technologies.

SCIENCE (2022)

Article Biology

Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomas

Alvin Wei Tian Ng, Gianmarco Contino, Sarah Killcoyne, Ginny Devonshire, Ray Hsu, Sujath Abbas, Jing Su, Aisling M. Redmond, Jamie M. J. Weaver, Matthew D. Eldridge, Simon Tavare, Paul A. W. Edwards, Rebecca C. Fitzgerald

Summary: This study categorizes genomic structural variants (SVs) in 383 cases of oesophageal cancer, uncovering mutational patterns and new disease drivers. Identification of SV events in OAC is crucial for targeted therapies.

COMMUNICATIONS BIOLOGY (2022)

Article Surgery

Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study)

Ajith K. Siriwardena

Summary: This study provides a global overview of the management of patients with acute cholecystitis during the early phase of the COVID-19 pandemic. The pandemic led to a decrease in surgical workforce and operating facilities, worse severity of disease, and increased use of conservative management. While the number of patients undergoing cholecystectomy decreased, there was no increase in post-operative mortality.

BJS OPEN (2022)

Article Oncology

eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma

Xiaoyu Wang, Puya Gharahkhani, David M. Levine, Rebecca C. Fitzgerald, Ines Gockel, Douglas A. Corley, Harvey A. Risch, Leslie Bernstein, Wong-Ho Chow, Lynn Onstad, Nicholas J. Shaheen, Jesper Lagergren, Laura J. Hardie, Anna H. Wu, Paul D. P. Pharoah, Geoffrey Liu, Lesley A. Anderson, Prasad G. Iyer, Marilie D. Gammon, Carlos Caldas, Weimin Ye, Hugh Barr, Paul Moayyedi, Rebecca Harrison, R. G. Peter Watson, Stephen Attwood, Laura Chegwidden, Sharon B. Love, David MacDonald, John DeCaestecker, Hans Prenen, Katja Ott, Susanne Moebus, Marino Venerito, Hauke Lang, Rupert Mayershofer, Michael Knapp, Lothar Veits, Christian Gerges, Josef Weismueller, Matthias Reeh, Markus M. Noethen, Jakob R. Izbicki, Hendrik Manner, Horst Neuhaus, Thomas Roesch, Anne C. Boehmer, Arnulf H. Hoelscher, Mario Anders, Oliver Pech, Brigitte Schumacher, Claudia Schmidt, Thomas Schmidt, Tania Noder, Dietmar Lorenz, Michael Vieth, Andrea May, Timo Hess, Nicole Kreuser, Jessica Becker, Christian Ell, Ian Tomlinson, Claire Palles, Janusz A. Jankowski, David C. Whiteman, Stuart MacGregor, Johannes Schumacher, Thomas L. Vaughan, Matthew F. Buas, James Y. Dai

Summary: This study identified novel genetic susceptibility loci for esophageal adenocarcinoma and Barrett esophagus using an eQTL set-based genetic association approach, expanding the pool of genetic susceptibility loci.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Review Geriatrics & Gerontology

The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: a systematic review

Patrick Casey, Mohamed Alasmar, John McLaughlin, Yeng Ang, Jamie McPhee, Priam Heire, Javed Sultan

Summary: Ultrasound is a promising tool for measuring skeletal muscle mass and quality, and can predict functional capacity, clinical outcomes, and survival. However, further standardization is needed before ultrasound can be widely used in nutritionally vulnerable patients.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Pathology

Barrett's oesophagus with indefinite for dysplasia shows high rates of prevalent and incident neoplasia in a UK multicentre cohort

Maja Kopczynska, Elizabeth Ratcliffe, Harika Yalamanchili, Anna Thompson, Adib Nimri, James Britton, Yeng Ang

Summary: IDD in Barrett's esophagus carries a significant risk of progression to dysplasia or neoplasia, highlighting the importance of accurate histological reporting for diagnosis and management.

JOURNAL OF CLINICAL PATHOLOGY (2022)

Article Multidisciplinary Sciences

HIRA loss transforms FH-deficient cells

Lorea Valcarcel-Jimenez, Connor Rogerson, Cissy Yong, Christina Schmidt, Ming Yang, Monica Cremades-Rodelgo, Victoria Harle, Victoria Offord, Kim Wong, Ariane Mora, Alyson Speed, Veronica Caraffini, Maxine Gia Binh Tran, Eamonn R. Maher, Grant D. Stewart, Sakari Vanharanta, David J. Adams, Christian Frezza

Summary: Depletion of HIRA enhances proliferation and invasion of Fh1-deficient cells by activating MYC and its target genes, leading to increased nucleotide metabolism specifically in Fh1-deficient cells. This finding is instrumental for understanding the mechanisms of tumorigenesis in HLRCC and developing targeted treatments for patients.

SCIENCE ADVANCES (2022)

Article Oncology

Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study

Colin Y. C. Lee, Adriaan Olivier, Judith Honing, Anne-Marie Lydon, Susan Richardson, Maria O'Donovan, Marc Tischkowitz, Rebecca C. Fitzgerald, Massimiliano di Pietro

Summary: Hereditary diffuse gastric cancer, caused by CDH1 gene mutations, is characterized by early-onset signet ring cell carcinoma. Prophylactic total gastrectomy is the recommended treatment. This study assessed different sampling strategies for detecting signet ring cell carcinoma and identified criteria for characterizing endoscopic lesions in hereditary diffuse gastric cancer.

LANCET ONCOLOGY (2023)

Article Oncology

Categorizing Risks within Barrett's Esophagus To Guide Surveillance and Interception; Suggesting a New Framework

Judith Honing, Rebecca C. Fitzgerald

Summary: Barrett's esophagus is a precancerous condition that can progress to esophageal adenocarcinoma. Surveillance is needed to detect progression, but current methods are limited. This commentary proposes incorporating new risk factors and tools, such as nonendoscopic triage and commercial biomarker panels, into clinical practice for better risk stratification.

CANCER PREVENTION RESEARCH (2023)

Article Cell Biology

FOXA2 controls the anti-oxidant response in FH-deficient cells

Connor Rogerson, Marco Sciacovelli, Lucas A. Maddalena, Andromachi Pouikli, Marc Segarra-Mondejar, Lorea Valcarcel-Jimenez, Christina Schmidt, Ming Yang, Elena Ivanova, Joshua Kent, Ariane Mora, Danya Cheeseman, Jason S. Carroll, Gavin Kelsey, Christian Frezza

Summary: Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a cancer syndrome caused by inactivating germ-line mutations in fumarate hydratase (FH) and subsequent accumulation of fumarate. Fumarate accumulation leads to profound epigenetic changes and the activation of an antioxidant response via nuclear translocation of the transcription factor NRF2. The identification of FOXA2 as an antioxidant regulator provides additional insights into the molecular mechanisms behind cell responses to fumarate accumulation and potentially provides further avenues for therapeutic intervention for HLRCC.

CELL REPORTS (2023)

Article Biochemistry & Molecular Biology

SMAD4 and KCNQ3 alterations are associated with lymph node metastases in oesophageal adenocarcinoma

Kieran Foley, David Shorthouse, Eric Rahrmann, Lizhe Zhuang, Ginny Devonshire, Rebecca C. OCCAMS Consortium, Rebecca C. Fitzgerald, Benjamin A. Hall

Summary: Metastasis in oesophageal adenocarcinoma (OAC) is a crucial factor affecting survival. Radiological staging is commonly used to assess metastases, but its accuracy is limited. This study analyzed lymph node metastases and identified new roles of genes SMAD4 and KCNQ3 in metastasis. The findings suggest that both genes could serve as novel biomarkers for metastatic risk and offer potential new targets for drug treatment.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

No Data Available